MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Long-Term Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study

    K. Anderson, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, L. Jarskog, J. Jimenez-Shahed, R. Kumar, S. Ochudlo, W. Ondo, H. Fernandez (Washington, DC, USA)

    Objective: To evaluate the long-term safety/tolerability of deutetrabenazine (DTB) in patients with tardive dyskinesia (TD). Week 54 open-label results are reported in this interim analysis.…
  • 2017 International Congress

    Motor dysfunctions in rats following repeated exposure to stress on the neurotoxicity of lambda-cyhalothrin

    R. Shukla, R. Gupta, A. Pant, V. Khanna (Lucknow, India)

    Objective: To investigate the targets associated in regulating motor functions following subsequent exposure to stress on the neurotoxicity of lambda-cyhalothrin in rats. Background: Stress that…
  • 2017 International Congress

    Hemidystonia Associated with Alexander Disease

    D. Vijayakumar, R. Lewis, G. Fuller, S. Dhar, K. Machol, L. Robak, J. Jankovic (Houston, TX, USA)

    Objective: To describe an uncommon movement disorder phenotype of Alexander disease (AD). Background: AD is a rare autosomal dominant disorder that causes progressive leukodystrophy, especially…
  • 2017 International Congress

    Whole Exome Sequencing (WES) identifies a TUBB4A Mutation in two Saudi siblings with hypomyelinating leukodystrophy associated with atrophy of basal ganglia and cerebellum.

    Z. Aldaajani, E.-S. Ali (Dhahran, Saudi Arabia)

    Objective: To highlight the presentation of TUBB4A mutations. Background: Hypomyelinating leukodystrophy, identified in 2002 by magnetic resonance imaging is a rare heterogeneous group of diseases…
  • 2017 International Congress

    Behavioral Changes on the UCSD Huntington’s Disease Behavioral Questionnaire (HD-BQ) Distinguish Patients Transitioning to Manifest Huntington’s disease (HD)

    S. Park, S. Nam, A. Nathan, A. Haque, A. Haque, P. Gilbert, J. Corey-Bloom (La Jolla, CA, USA)

    Objective: To utilize the UCSD Huntington's Disease Behavioral Questionnaire (HD-BQ) to assess behavioral changes that distinguish HD gene carriers transitioning to manifest HD. Background: Behavioral…
  • 2017 International Congress

    A Descriptive Analysis of a Real-World Population With Huntington Disease-Associated Chorea (HDAC) Treated With Tetrabenazine: Findings From an Electronic Medical Records (EMR) Database

    R. Iver, D. Alevras, S. Gandhi, T. Schilling, V. Abler, F. Cao, K. Johnson, K. Anderson (Frazer, PA, USA)

    Objective: To examine clinical and treatment information about HDAC in patients (pts) prescribed tetrabenazine (TBZ). Background: Huntington disease is a hereditary movement disorder, with chorea…
  • 2017 International Congress

    Parkinson ‘ s disease and Peripheral Nervous System  : Wax and Waning Non-motor offs and Levodopa-use Topics

    s.g. echebarria mendieta (-, Spain)

    Objective: To relate the non-motor offs theory , sensory signs and levodopa use with neurophysiiology  terms in PD Background: Peripheral Nervous System disease concept in…
  • 2017 International Congress

    Serum soluble transferrin receptor levels correlate with the Hoehn & Yahr stage of Parkinson disease progression

    P. Costa-Mallen, S.-C. Hu, P. Agarwal (Kenmore, WA, USA)

    Objective: To test whether levels of soluble transferrin receptor (sTfR) in the serum of Parkinson disease (PD) patients are correlated with the progression of the disease…
  • 2017 International Congress

    New device HANABI (HANdai Amyloid Burst Inducer) is a rapid and sensitive detecting system of α synuclein fibril in CSF from Parkinson’s disease patients

    K. Ikenaka, K. Araki, M. So, S. Hashimoto, T. Tokuda, Y. Goto, H. Mochizuki (Suita, Japan)

    Objective: Early diagnosis for PD is disturbed by the lack of sensitive and objective detection of accumulated αSyn in the patient’s brain. Recently, Real-Time Quaking-Induced…
  • 2017 International Congress

    Objective identification of freezing of gait in Parkinson’s disease patients using a triaxial accelerometer

    Y. Okuma, H. Mitoma, M. Yoneyama (Izunokuni-city, Japan)

    Objective:  The aim of this study is to objectively detect and quantify freezing of gait (FOG) in Parkinson’s disease (PD) patients during everyday activities.   Background:…
  • « Previous Page
  • 1
  • …
  • 113
  • 114
  • 115
  • 116
  • 117
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley